Minimally-Invasive MitraClip Therapy For Severe Mitral Regurgitation (DMR)

Minimally-Invasive MitraClip Therapy For Severe Mitral Regurgitation (DMR)

0
0
17642 days ago, 551 views

Cardiology

Certain high-surgical-risk patients with severe degenerative mitral regurgitation (DMR) now have a minimally invasive treatment option. MitraClip® therapy is a minimally-invasive transcatheter mitral valve repair (TMVr) procedure that has been established as a proven option with demonstrated safety and clinically important improvements. Used in more than 25,000 patients worldwide, MitraClip® is a well-established therapy. The MitraClip® device received CE Mark approval in Europe in 2008 and U.S. FDA approval in 2013, and has been approved for commercial use in 50 countries throughout the world.

1000 chars left
No comments found.